State Insulin Price Caps Seen as New Front in Drug Price Fight

State lawmakers can better aid communities bearing the brunt of high insulin prices by expanding policies to cover the uninsured and addressing practices of drug industry middlemen, analysts and patient groups say.

A Democratic state lawmaker in Wisconsin recently proposed a bill that would cap the price of insulin at $35 for residents with state-regulated commercial health plans. Legislatures in others states, including Massachusetts and Pennsylvania, are also considering proposals that would add them to the list of 25 states that currently limit copayments for patients covered by commercial plans.

In California, Gov. Gavin Newsom (D) recently vetoed a bill ...